Skip to main content
Advertisement
Advertisement

IGC

IGC logo

IGC Pharma, Inc.

0.27
USD
Sponsored
+0.01
+3.28%
Sep 22, 15:59 UTC -4
Closed
exchange

Pre-Market

0.28

+0.01
+2.19%

IGC Earnings Reports

Positive Surprise Ratio

IGC beat 4 of 6 last estimates.

67%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 27 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

IGC Pharma, Inc. earnings per share and revenue

On Aug 12, 2026, IGC reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 248.46 thousand, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
FAQ
For Q1 2027, IGC Pharma, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, IGC Pharma, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement